美敦力
MDT101.000USD
+0.210+0.21%
收盘 01/29, 16:00（美东）报价延迟15分钟
129.48B总市值
27.18市盈率 TTM
关于 美敦力 公司
Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
美敦力简介
公司代码MDT
公司名称Medtronic PLC
上市日期Nov 21, 1977
CEOMartha (Geoffrey S)
员工数量95000
证券类型Ordinary Share
年结日Nov 21
公司地址Building Two Parkmore Business Park West
城市DUBLIN
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家Ireland
邮编H91 4K49
电话1135314381700
网址https://www.medtronic.com/
公司代码MDT
上市日期Nov 21, 1977
CEOMartha (Geoffrey S)
美敦力公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.90M
-1564.00%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
548.17K
-439.00%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-3541.00%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
48.84K
+890.00%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
48.26K
-1371.00%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
40.24K
+73.00%
Mr. Scott C. Donnelly
Mr. Scott C. Donnelly
Independent Director
Independent Director
21.71K
+192.00%
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Independent Director
Independent Director
17.64K
+72.00%
Mr. Kevin E. Lofton
Mr. Kevin E. Lofton
Independent Director
Independent Director
8.19K
+72.00%
Mr. Thierry Jean Louis Pieton
Mr. Thierry Jean Louis Pieton
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
7.39K
-32060.00%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.90M
-1564.00%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
548.17K
-439.00%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-3541.00%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
48.84K
+890.00%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
48.26K
-1371.00%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
40.24K
+73.00%
收入明细
单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Cardiac Rhythm & Heart Failure
1.82B
20.37%
Surgical & Endoscopy
1.68B
18.74%
Cranial & Spinal Technologies
1.30B
14.50%
Structural Heart & Aortic
956.00M
10.67%
Specialty Therapies
744.00M
8.30%
其他
2.46B
27.43%
地区USD
名称
营收
占比
United States
4.52B
50.40%
Rest of World
4.41B
49.21%
Ireland
35.00M
0.39%
业务
地区
业务USD
名称
营收
占比
Cardiac Rhythm & Heart Failure
1.82B
20.37%
Surgical & Endoscopy
1.68B
18.74%
Cranial & Spinal Technologies
1.30B
14.50%
Structural Heart & Aortic
956.00M
10.67%
Specialty Therapies
744.00M
8.30%
其他
2.46B
27.43%
股东统计
更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
10.01%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Investment Management (US)
4.72%
JP Morgan Asset Management
2.92%
Capital Research Global Investors
2.39%
其他
74.78%
持股股东
持股股东
占比
The Vanguard Group, Inc.
10.01%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Investment Management (US)
4.72%
JP Morgan Asset Management
2.92%
Capital Research Global Investors
2.39%
其他
74.78%
股东类型
持股股东
占比
Investment Advisor
46.88%
Investment Advisor/Hedge Fund
29.43%
Research Firm
4.36%
Pension Fund
2.40%
Bank and Trust
2.16%
Hedge Fund
1.41%
Sovereign Wealth Fund
1.37%
Insurance Company
0.38%
Individual Investor
0.28%
其他
11.33%
机构持股
更新时间: 1月1日 周四
更新时间: 1月1日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q4
3674
1.13B
88.21%
-17.18M
2025Q3
3723
1.13B
88.20%
-2.77M
2025Q2
3762
1.12B
87.12%
-18.03M
2025Q1
3818
1.13B
88.15%
+2.18M
2024Q4
3768
1.12B
87.17%
+3.13M
2024Q3
3708
1.10B
85.63%
-24.55M
2024Q2
3725
1.11B
86.25%
-54.16M
2024Q1
3789
1.14B
85.95%
-7.87M
2023Q4
3780
1.13B
85.36%
-20.57M
2023Q3
3761
1.14B
85.37%
-14.93M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
130.95M
10.21%
+4.49M
+3.55%
Nov 28, 2025
BlackRock Institutional Trust Company, N.A.
66.42M
5.18%
-1.42M
-2.10%
Sep 30, 2025
State Street Investment Management (US)
60.46M
4.72%
+625.99K
+1.05%
Sep 30, 2025
JP Morgan Asset Management
37.48M
2.92%
+11.18M
+42.48%
Sep 30, 2025
Capital Research Global Investors
30.69M
2.39%
-5.67M
-15.58%
Sep 30, 2025
Geode Capital Management, L.L.C.
27.65M
2.16%
-579.44K
-2.05%
Sep 30, 2025
MFS Investment Management
19.44M
1.52%
+75.05K
+0.39%
Sep 30, 2025
Norges Bank Investment Management (NBIM)
16.44M
1.28%
+1.87M
+12.83%
Jun 30, 2025
Managed Account Advisors LLC
14.98M
1.17%
+1.21M
+8.79%
Sep 30, 2025
BlackRock Financial Management, Inc.
14.32M
1.12%
-1.30M
-8.33%
Sep 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Absolute Select Value ETF
4.89%
iShares U.S. Medical Devices ETF
4.4%
iShares Health Innovation Active ETF
4.26%
Cullen Enhanced Equity Income ETF
4.24%
USCF Dividend Income Fund
3.59%
JPMorgan Healthcare Leaders ETF
3.22%
Madison Dividend Value ETF
3.08%
Tema Heart & Health ETF
2.98%
Global X Aging Population ETF
2.98%
WisdomTree US AI Enhanced Value Fund
2.86%
查看更多
Absolute Select Value ETF
占比4.89%
iShares U.S. Medical Devices ETF
占比4.4%
iShares Health Innovation Active ETF
占比4.26%
Cullen Enhanced Equity Income ETF
占比4.24%
USCF Dividend Income Fund
占比3.59%
JPMorgan Healthcare Leaders ETF
占比3.22%
Madison Dividend Value ETF
占比3.08%
Tema Heart & Health ETF
占比2.98%
Global X Aging Population ETF
占比2.98%
WisdomTree US AI Enhanced Value Fund
占比2.86%
分红派息
近5年累计派现
17.37B
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Dec 04, 2025
MDT.NB Interim Cash Dividend of gross USD 0.71 paid on Jan 16, 2026 going ex on Dec 26, 2025 with reinvestment option
Dec 26, 2025
Jan 16, 2026
Dec 26, 2025
Aug 14, 2025
MDT.NB Interim Cash Dividend of gross USD 0.71 paid on Oct 17, 2025 going ex on Sep 26, 2025 with reinvestment option
Sep 26, 2025
Oct 17, 2025
Sep 26, 2025
May 21, 2025
MDT.NB Interim Cash Dividend of gross USD 0.71 paid on Jul 11, 2025 going ex on Jun 27, 2025 with reinvestment option
Jun 27, 2025
Jul 11, 2025
Jun 27, 2025
Mar 06, 2025
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Apr 11, 2025 going ex on Mar 28, 2025 with reinvestment option
Mar 28, 2025
Apr 11, 2025
Mar 28, 2025
Dec 05, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jan 10, 2025 going ex on Dec 27, 2024 with reinvestment option
Dec 27, 2024
Jan 10, 2025
Dec 27, 2024
Aug 16, 2024
MDT.NB Final Cash Dividend of gross USD 0.7 paid on Oct 11, 2024 going ex on Sep 27, 2024 with reinvestment option
Sep 27, 2024
Oct 11, 2024
Sep 27, 2024
May 23, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jul 12, 2024 going ex on Jun 28, 2024 with reinvestment option
Jun 28, 2024
Jul 12, 2024
Jun 28, 2024
Mar 07, 2024
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Apr 12, 2024 going ex on Mar 21, 2024 with reinvestment option
Mar 22, 2024
Apr 12, 2024
Mar 21, 2024
Dec 07, 2023
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jan 12, 2024 going ex on Dec 19, 2023
Dec 20, 2023
Jan 12, 2024
Dec 19, 2023
Aug 17, 2023
MDT.NB Final Cash Dividend of gross USD 0.69 paid on Oct 13, 2023 going ex on Sep 21, 2023 with reinvestment option
Sep 22, 2023
Oct 13, 2023
Sep 21, 2023
查看更多
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
